Earlier this year, we discussed our plan for program prioritization and focused expense management, and we have successfully executed in both areas. First half total operating expenses declined 22% year over year, with G&A expenses for the six-month period ending June 30, 2024, decreasing to approximately $4.3 million, compared to $5.5 million for the same period in 2023. R&D expenses for the six months ended June 30, 2024, also decreased approximately $1.2 million, or 22%, to approximately $3.9 million.

Aug 14, 2024 / CFO / receipt, needs a key / Lisa Locklear, CFO | earnings call 2024-08-14 | transcript 192ac438-b871-4c98-9c6f-105cf0ac633b | chars 14141-14650 | segment 14